Compare TJGC & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TJGC | DRIO |
|---|---|---|
| Founded | 2022 | 2011 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.1M | 52.8M |
| IPO Year | 2023 | 2013 |
| Metric | TJGC | DRIO |
|---|---|---|
| Price | $3.97 | $7.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 990.5K | 27.5K |
| Earning Date | 08-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.75 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | ★ N/A | $4.33 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $0.49 | $0.43 |
| 52 Week High | $7.07 | $17.74 |
| Indicator | TJGC | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 42.78 | 53.79 |
| Support Level | $0.80 | $7.18 |
| Resistance Level | $5.01 | $8.29 |
| Average True Range (ATR) | 0.44 | 0.81 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 34.96 | 68.53 |
TJGC Group Ltd, formerly CTRL Group Ltd is an integrated marketing and advertising services provider in Hong Kong specializing in mobile games promotion for the local market. It provide services to mobile game developers, principally developers of mobile gaming applications or apps that gamers download from the developers' websites and applicable mobile operating systems, such as Apple Store or Android Google Play Store.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.